Infection

, 39:399 | Cite as

Excess mortality from seasonal influenza is negligible below the age of 50 in Israel: implications for vaccine policy

  • Y. Linhart
  • T. Shohat
  • M. Bromberg
  • E. Mendelson
  • R. Dictiar
  • M. S. Green
Clinical and Epidemiological Study

Abstract

Purpose

Evaluation of the severity of pandemic influenza requires reliable estimates of mortality attributable to the seasonal influenza.

Methods

Excess age-specific mortality during periods of influenza activity was evaluated in Israel during the period 1999–2006 for three death categories. For each respiratory year, the lowest monthly moving average for the mortality rate was subtracted from each month in the period of influenza activity. Average mortality rates in years with minimal influenza activity were deducted from corresponding months to exclude winter mortality unrelated to influenza. The sums of these results were used as estimates of excess mortality rates.

Results

Overall excess mortality rates ranged from 7.7 to 36.1 per 100,000 for all causes, and from 4.4 to 24.4 per 100,000 for respiratory and circulatory causes. Influenza was associated with an average of 869 (range 280–1,516) deaths annually from respiratory and circulatory diseases during seasons with significant influenza activity. About 90% of the influenza-associated mortality from respiratory and circulatory diseases was in the age group 65+ years and about 1% in the age group <50 years. The age group <50 years accounted for an annual average of seven deaths from respiratory and circulatory diseases.

Conclusion

Annual mortality associated with seasonal influenza is highly variable. Under the age of 50 years, there is minimal seasonal influenza associated mortality. This information provides an important baseline for evaluating the severity of the A(H1N1) 2009 influenza pandemic, where persons under 50 years of age were often disproportionately represented.

Keywords

Influenza Mortality Season Age-specific Israel 

References

  1. 1.
    Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.PubMedCrossRefGoogle Scholar
  2. 2.
    Wong CM, Chan KP, Hedley AJ, Peiris JS. Influenza-associated mortality in Hong Kong. Clin Infect Dis. 2004;39:1611–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–59.PubMedCrossRefGoogle Scholar
  4. 4.
    Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect. 1996;116:51–63.PubMedCrossRefGoogle Scholar
  5. 5.
    Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA. 1999;281:901–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Flahault A. First estimation of direct H1N1pdm virulence. From reported non consolidated data from Mauritius and New Caledonia. PLoS Curr Influenza: http://knol.google.com/k/antoine-flahault/first-estimation-of-direct-h1n1pdm/2nsp4xxomyqub/1#references. Accessed 27 Aug 2009.
  7. 7.
    Tsigrelis C, Mohammad M, Fraimow HS, Dellinger RP, Marchesani D, Reboli AC. Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection. Infection. 2010;38:237–9.Google Scholar
  8. 8.
    Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87:1944–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Thompson WW, Weintraub E, Dhankhar P, et al. Estimation of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses. 2009;3:37–49.PubMedCrossRefGoogle Scholar
  10. 10.
    Rizzo C, Bella A, Viboud C, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969–2001. Emerg Infect Dis. 2007;13:694–9.PubMedGoogle Scholar
  11. 11.
    Zucs P, Buchholz U, Haas W, Uphoff H. Influenza associated excess mortality in Germany, 1985–2001. Emerg Themes Epidemiol. 2005;2:6.PubMedCrossRefGoogle Scholar
  12. 12.
    Donaldson GC, Keatinge WR. Excess winter mortality: influenza or cold stress? Observational study. Br Med J. 2002;324:89–90.CrossRefGoogle Scholar
  13. 13.
    Green MS, Harari G, Kristal-Boneh E. Excess winter mortality from ischaemic heart disease and stroke during colder and warmer years in Israel. Eur J Public Health. 1994;4:3–11.CrossRefGoogle Scholar
  14. 14.
    Analitis A, Katsouyanni K, Biggeri A, et al. Effects of cold weather on mortality: results from 15 European cities within the PHEWE project. Am J Epidemiol. 2008;168:1397–408.PubMedCrossRefGoogle Scholar
  15. 15.
    World Health Organization. Preparing for the second wave: lessons from current outbreaks. 2009 Aug 28: http://www.who.int/csr/disease/swineflu/notes/h1n1_second_wave_20090828/en/index.html. Accessed 11 Oct 2009.
  16. 16.
    Shohat T, Versano N, Kiro A, Golan G, Mendelson E, Weingarten M. Use of sentinel reporting clinics for influenza surveillance in winter of 1996–1997 (in Hebrew). Harefuah. 1999;136:177–80.PubMedGoogle Scholar
  17. 17.
    Peled T, Weingarten M, Varsano N, et al. Influenza surveillance during winter 1997–1998 in Israel. Isr Med Assoc J. 2001;3:911–4.PubMedGoogle Scholar
  18. 18.
    Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L. Mortality due to influenza in the United States—an annualized regression approach using multiple-cause mortality data. Am J Epidemiol. 2006;163:181–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Brinkhof MW, Spoerri A, Birrer A, Hagman R, Koch D, Zwahlen M. Influenza-attributable mortality among the elderly in Switzerland. Swiss Med Wkly. 2006;136:302–9.PubMedGoogle Scholar
  20. 20.
    Fiore AE, Sha DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines. Recommendation of the advisory committee on immunization practices (ACIP). MMWR 2009;58:RR-8: http://www.cdc.gov/mmwr/PDF/rr/rr5808.pdf. Accessed 11 Nov 2009.
  21. 21.
    Knycl J, Prochazka B, Goddard NL, et al. A study of excess mortality during influenza epidemics in the Czech Republic, 1982–2000. Eur J Epidemiol. 2005;20:365–71.CrossRefGoogle Scholar
  22. 22.
    Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Infection 2009;37:390–400.Google Scholar
  23. 23.
    Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178:53–60.PubMedGoogle Scholar
  24. 24.
    Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165:265–72.PubMedCrossRefGoogle Scholar
  25. 25.
    Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959–1999. Am J Epidemiol. 2004;160:492–502.PubMedCrossRefGoogle Scholar
  26. 26.
    Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep. 1963;78:494–506.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Y. Linhart
    • 1
    • 2
  • T. Shohat
    • 2
    • 3
  • M. Bromberg
    • 3
  • E. Mendelson
    • 2
    • 4
  • R. Dictiar
    • 3
  • M. S. Green
    • 5
  1. 1.Tel Aviv District Health Office Ministry of HealthTel-AvivIsrael
  2. 2.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael
  3. 3.Israel Center for Disease Control Ministry of HealthTel HashomerIsrael
  4. 4.Central Virology Laboratory Ministry of HealthTel HashomerIsrael
  5. 5.School of Public HealthUniversity of HaifaHaifaIsrael

Personalised recommendations